| Ytd | 57.89% | |
| 1y | 97.80% |
| Open | 131.87 | Prev Close | 131.87 | Low | 131.87 | High | 131.87 | Mkt Cap | 14.05B |
| Vol | 16.04M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | 507.19 |
| Beta | 0.46 | Short Ratio | 1.20 | Inst. Own | 96.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 132.00 |
VOQUEZNA launch momentum continues with over 390,000 prescriptions filled to date, written by more t
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenu
Intra-Cellular Therapies (ITCI) came out with a quarterly loss of $0.16 per share versus the Zacks C
Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million , representing a 51% increase o
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising
NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investiga
JNJ is set to acquire ITCI for $132 per share in cash. The transaction is likely to close before thi
Intra-Cellular (ITCI) witnessed a jump in share price last session on above-average trading volume.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Intra-Cellular Therapies (Nasdaq: ITCI) for p
Intra-Cellular +32.49 (+34.25%) Johnson & Johnson +2.22 (+1.56%)
Intra-Cellular stock gains 15% as it settles Caplyta patent litigation with Sandoz protecting the dr
Drugmakers signed deals worth at least $18 billion in combined value on Monday, the first day of the
Intra-Cellular +32.2 (+33.94%) Johnson & Johnson +1.38 (+0.97%)
Shares of Intra-Cellular Therapies (ITCI) are surging 35% in premarket trading Monday after Johnson
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Intra-Cellular (ITCI) was a big mover last session on higher-than-average trading volume. The latest
Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 bil
Top performers in last week's stock market: Walgreens, Constellation Energy, FTAI Aviation, TD S
Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+1
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company re
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Gainers
On Friday, 497 companies set new 52-week lows.
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss a
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor
Upgrades
Upgrades
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly
Upgrades
On Thursday, 75 stocks made new 52-week highs.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing hi
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday afte
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9%
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55.
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the F